Physician profile

Thomas Jun Hong

Interventional Pain Medicine · Mansfield, TX

NPI 1144563354

$8,336.38

in general payments reported to CMS, 2019-2025

52 companies · $1,883 in 2025

The $1,883 reported for 2025 was more than what 77% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$3,198.09
Travel and Lodging$69.82

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Boston Scientific Corporation $2,102.99 2019-2025 Intracept, Wavewriter Alpha Prime 16
Biotronik Nro, INC. $1,047.02 2023-2025 Prospera, Biotronik
Nevro Corp. $708.48 2019-2024 Senza
Abbott Laboratories $414.52 2019-2025 Eterna, Proclaim
Medtronic USA, INC. $363.58 2019
Scilex Pharmaceuticals INC. $354.99 2019-2024 Ztlido
Horizon Therapeutics Plc $310.07 2019-2022
Abbvie INC. $280.76 2021-2024
Spinal Simplicity, LLC $277.89 2022-2025 Ha Minuteman G3-R
Si-Bone, INC. $192.91 2024-2025
Salix Pharmaceuticals, A Division of Bausch Health US, LLC $180.99 2019-2025 Relistor
Azurity Pharmaceuticals, INC. $159.08 2023-2025 Horizant, Horizant
Spr Therapeutics, INC $152.93 2025 Sprint Pns System
Novartis Pharmaceuticals Corporation $125.98 2019-2021
Collegium Pharmaceutical, INC. $123.33 2019-2021
Show all 52 companies
CompanyGeneral paymentsYearsTop products
Saluda Medical Americas, INC. $118.38 2023-2025 Evoke, Evoke Scs
Vertiflex, INC. $116.25 2019
Arbor Pharmaceuticals, INC. $108.83 2019-2022
Fidia Pharma USA INC. $85.91 2020-2025 Hymovis, Triluron
Vertex Pharmaceuticals Incorporated $82.95 2025
Idorsia Pharmaceuticals US INC $74.58 2022-2023 Quviviq
Curonix LLC $69.82 2025 Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A
Avanos Medical $60.91 2024-2025 Generator, Standard Rf Disposables
Averitas Pharma INC. $49.61 2025 Qutenza
Zyla Life Sciences, INC. $49.51 2019
Pfizer INC. $45.33 2019-2025
Almatica Pharma LLC $43.61 2023 Gralise
Teva Pharmaceuticals USA, INC. $43.33 2020
Ibsa Pharma INC. $42.99 2023-2024 Tirosint, Tirosint, Licart
Eisai INC. $42.12 2020
Forte Bio-Pharma LLC $41.50 2022
Depuy Synthes Sales INC. $39.05 2024-2025 Monovisc, Orthovisc
Amgen INC. $34.74 2020-2022
Medtronic, INC. $32.86 2024 Intellis Adaptivestim
Lilly USA, LLC $32.49 2019
Djo, LLC $30.22 2020-2022
Bioventus LLC $25.82 2020
Stryker Corporation $25.34 2025 Mild Device Kit
Daiichi Sankyo INC. $25.28 2019
Convatec INC. $25.02 2024
Valinor Pharma, LLC $19.70 2024 Movantik
Allergan, INC. $19.61 2020
Baudax Bio INC. $18.50 2020
Pernix Therapeutics Holdings, INC. $17.45 2019
Biodelivery Sciences International, INC. $16.76 2020
Tonix Medicines, INC. $15.84 2025 Tonmya
Uswm, LLC $15.29 2022
Mdd US Operations, LLC $15.17 2019
Aytu Biopharma, INC. $15.12 2020
Biohaven Pharmaceuticals, INC. $14.09 2021
Painteq LLC $13.92 2023 Painteq
Metacel Pharmaceuticals LLC $12.96 2023 Ozobax

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Thomas Jun Hong

$8,336.38

in general payments reported 2019-2025

Years
2019-2025
Top company
Boston Scientific Corporation
Context
The $1,883 reported for 2025 was more than what 77% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).

https://glasscript.com/doctor/4223906/thomas-jun-hong

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.